BioSpace News Archive

Warm antibody hemolytic anemia is a highly common form of autoimmune hemolytic anemia. It is the presence of autoantibodies that attach to and destroy red blood cells at temperatures equal to or greater than normal body temperature.

Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures.

Anxiety is associated with an increased rate of progression from mild cognitive impairment to Alzheimer’s disease, according to a study being presented at the annual meeting of the Radiological Society of North America.

Transparency Market Research has published a new report titled, ‘Antithrombin Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Immuron Limited is pleased to announce that under the Australian Government’s Research and Development Income Tax Concession incentive program, the Company has received a cash refund of AUD $358,280 for eligible research and development expenditure incurred during the 2020 Financial Year.

United Therapeutics Corporation announced the release of its initial Corporate Responsibility Report with primarily 2019 data and selected 2020 highlights, providing stakeholders important information regarding the company’s commitment to environmental, social, and governance priorities.

MediciNova, Inc. announced that Good Manufacturing Practice -based Master Virus Seed Stock production of its novel intranasal SARS-CoV-2 vaccine for COVID-19, using BC-PIV technology, has been initiated at Millipore Sigma BioReliance Services, a group company of Merck KGaA, Darmstadt, Germany.

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Mark Pruzanski, M.D., President and Chief Executive Officer, Sandip Kapadia, Chief Financial Officer, and Gail Cawkwell, M.D., Ph.D., SVP, Medical Affairs, Safety and Pharmacovigilance of Intercept, will participate in a fireside chat at th

Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in the Piper Sandler 32 nd Annual Health Care Conference being held virtually on December 1-3, 2020. Investors interested in a 1x1 meeting with Ra Medical management during the conference should contact their Pip

TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference. Conference Dates: Tuesday, December 1 to Thursday, December 3, 2020. A link to the fireside chat prese